About site:

Domain name - bristol-meyers-squibb.biz

Site title - Edge IP Restricted | bristol-meyers-squibb.biz | Cloudflare

Go to website - Edge IP Restricted | bristol-meyers-squibb.biz | Cloudflare

Site GEO location

Registration Country - Australia

Provider - CLOUDFLARENET

Site Logo

IP address:

1.1.1.1

Domain name servers:

ns4.bms.com ns2.bms.com ns3.bms.com ns1.bms.com

All records:

☆ bristol-meyers-squibb.biz. 21600 IN NS ns2.bms.com.
☆ bristol-meyers-squibb.biz. 21600 IN NS ns1.bms.com.
☆ bristol-meyers-squibb.biz. 21600 IN NS ns4.bms.com.
☆ bristol-meyers-squibb.biz. 21600 IN NS ns3.bms.com.
☆ bristol-meyers-squibb.biz. 21600 IN A 1.1.1.1
☆ bristol-meyers-squibb.biz. 21600 IN MX 10 chimera.bms.com.
☆ bristol-meyers-squibb.biz. 21600 IN MX 20 loki.bms.com.
☆ bristol-meyers-squibb.biz. 21600 IN SOA ns1.bms.com. dnsadmin.bms.com. 2011111406 10800 3600 604800 600

Number of allowed queries exceeded.

Brief facts about bristol meyers squibb:

Abatacept
Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody.

Amylin Pharmaceuticals
Amylin Pharmaceuticals was a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases.

Apixaban
Apixaban, sold under the brand name Eliquis among others, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation.

Aripiprazole
Aripiprazole, sold under the brand names Abilify and Aristada among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia and bipolar disorder.

Atazanavir
Atazanavir, sold under the brand name Reyataz among others, is an antiretroviral medication used to treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.

Atazanavir/cobicistat
Atazanavir/cobicistat, sold under the brand name Evotaz, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS. It contains atazanavir and cobicistat.

Azacitidine
Azacitidine, sold under the brand name Vidaza among others, is used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia.

Aztreonam
Aztreonam, sold under the brand name Azactam among others, is an antibiotic used primarily to treat infections caused by gram-negative bacteria such as Pseudomonas aeruginosa. This may include bone infections, endometritis, intra abdominal infections, pneumonia, urinary tract infections, and sepsis.

Belatacept
Belatacept, sold under the brand name Nulojix, is a fusion protein composed of the Fc fragment of a human IgG1 immunoglobulin linked to the extracellular domain of CTLA-4, which is a molecule crucial in the regulation of T cell costimulation, selectively blocking the process of T-cell activation.

BMS-564,929
BMS-564,929 is an investigational selective androgen receptor modulator which is being developed by Bristol-Myers Squibb for treatment of the symptoms of age-related decline in androgen levels in men.

Bristol Myers Squibb
Bristol Myers Squibb is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

Bristol-Myers Squibb
Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City.

Bristol-Myers Squibb Co. v. Superior Court
Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 582 U.S. ___, was a United States Supreme Court case in which the Court held that California courts lacked personal jurisdiction over the defendant on claims brought by plaintiffs who are not California residents and...

Brivanib alaninate
Brivanib alaninate also known as BMS-582664 is an investigational, anti-tumorigenic drug for oral administration. The drug is being developed by Bristol-Myers Squibb for the treatment of hepatocellular carcinoma or HCC, the most common type of liver cancer.

Captopril
Captopril, sold under the brand name Capoten among others, is an angiotensin-converting enzyme inhibitor used for the treatment of hypertension and some types of congestive heart failure. Captopril was the first oral ACE inhibitor found for the treatment of hypertension.

Celgene
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid, which is used in the treatment of multiple myeloma, and also in certain anemias.

Censavudine
Censavudine, is an investigational new drug being developed by Bristol Myers-Squibb for the treatment of HIV infection. It was originally developed at Yale University.

Cetuximab
Cetuximab is an epidermal growth factor receptor inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer.

Clairol
Clairol is the American personal care-product division of company Wella, specializing in hair coloring and hair care.

Clazakizumab
Clazakizumab, an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6. Clazakizumab was developed by Bristol Myers Squib and Alder Biopharmaceuticals.

Clopidogrel
Clopidogrel, sold under the brand name Plavix among others, is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.

Dapagliflozin
Dapagliflozin, sold under the brand names Farxiga and Forxiga among others, is a medication used to treat type 2 diabetes. It is also used to treat adults with certain kinds of heart failure and chronic kidney disease.

Dasatinib
Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive. It is taken by mouth.

Didanosine
Didanosine, sold under the brand name Videx, is a medication used to treat HIV/AIDS. It is used in combination with other medications as part of highly active antiretroviral therapy. It is of the reverse-transcriptase inhibitor class.

Efavirenz
Efavirenz, sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure.

Efavirenz/emtricitabine/tenofovir
Efavirenz/emtricitabine/tenofovir, sold under the brand name Atripla among others, is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It contains efavirenz, emtricitabine, and tenofovir disoproxil. It can be used by itself or together with other antiretroviral medications.

Eldelumab
Eldelumab is a fully human monoclonal antibody that targets chemokine ligand 10/Interferon-γ-inducible protein-10 designed for the treatment of Crohn's disease and ulcerative colitis. This drug was developed by Bristol-Myers Squibb and Medarex.

Elotuzumab
Elotuzumab, sold under the brand name Empliciti, is a humanized IgG1 monoclonal antibody medication used in combination with lenalidomide and dexamethasone, for adults that have received 1 to 3 prior therapies for the treatment of multiple myeloma.

Enasidenib
Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 gene, determined by an FDA-approved IDH2 companion diagnostic test. It is an inhibitor of IDH2.

Entecavir
Entecavir, sold under the brand name Baraclude, is an antiviral medication used in the treatment of hepatitis B virus infection. In those with both HIV/AIDS and HBV antiretroviral medication should also be used. Entecavir is taken by mouth as a tablet or solution.

E. R. Squibb
Edward Robinson Squibb was a medical doctor, a leading American inventor, and manufacturer of pharmaceutics who founded E. R. Squibb and Sons, which eventually became part of the modern pharmaceutical giant Bristol-Myers Squibb.

Fedratinib
Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. It is used in the form of fedratinib hydrochloride capsules that are taken by mouth. It is a semi-selective inhibitor of Janus kinase 2.

Glibenclamide/metformin
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.

Herman Sokol
Herman Sokol was an American chemist who was a co-discoverer of tetracycline. He was president of Bristol-Myers Company from 1976 to 1981.

Hydroxycarbamide
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia and cervical cancer. In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks. It is taken by mouth.

Idecabtagene vicleucel
Idecabtagene vicleucel, sold under the brand name Abecma, is a cell-based gene therapy to treat multiple myeloma. The most common side effects include cytokine release syndrome, infections, fatigue, musculoskeletal pain, and a weakened immune system.

Infant formula
Infant formula, baby formula or just formula or baby milk, infant milk, false milk, or first milk, is a manufactured food designed and marketed for feeding to babies and infants under 12 months of age, usually prepared for bottle-feeding or cup-feeding from powder or liquid.

Ipilimumab
Ipilimumab, sold under the brand name Yervoy, is a monoclonal antibody medication that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system. Cytotoxic T lymphocytes can recognize and destroy cancer cells.

Irbesartan
Irbesartan, sold under the brand name Avapro among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth.

Ixabepilone
Ixabepilone is a pharmaceutical drug developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer.

Lamberto Andreotti
Lamberto Andreotti is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb.

Lenalidomide
Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes. For multiple myeloma, it is used after at least one other treatment and generally with dexamethasone. It is taken by mouth.

Lirilumab
Lirilumab is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb.

Lisocabtagene maraleucel
Lisocabtagene maraleucel, sold under the brand name Breyanzi, is a cell-based gene therapy used to treat large B-cell lymphoma. Side effects include hypersensitivity reactions, serious infections, low blood cell counts, and a weakened immune system.

Lulizumab pegol
Lulizumab pegol is a monoclonal antibody designed for the treatment of autoimmune diseases.

Luspatercept
Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. The U.S. Food and Drug Administration considers it to be a first-in-class medication.

Mavacamten
Mavacamten, sold under the brand name Camzyos, is a medication used to treat obstructive hypertrophic cardiomyopathy. Mavacamten is a cardiac myosin inhibitor. It was developed by the MyoKardia subsidiary of Bristol Myers Squibb.

Medarex
Medarex was an American biopharmaceutical company based in Princeton, New Jersey, with manufacturing facilities in Bloomsbury and Annandale, New Jersey, and research facilities in Milpitas and Sunnyvale, California. In 2009, Medarex was purchased by Bristol Myers Squibb.

Nivolumab
Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer.

Nivolumab/relatlimab
Nivolumab/relatlimab, sold under the brand name Opdualag, is a fixed-dose combination medication use to treat melanoma. It contains nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene-3 blocking antibody. It is given by intravenous infusion.

Ozanimod
Ozanimod, sold under the brand name Zeposia, is an immunomodulatory medication for the treatment of relapsing multiple sclerosis and ulcerative colitis.

Paclitaxel
Paclitaxel, sold under the brand name Taxol among others, is a chemotherapy medication used to treat a number of types of cancer. This includes ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer.

Peter R. Dolan
Peter R. Dolan is an American business executive.

Pexacerfont
Pexacerfont is a drug developed by Bristol-Myers Squibb which acts as a CRF₁ antagonist. Corticotropin-releasing factor, also known as corticotropin-releasing hormone, is an endogenous peptide hormone which is released in response to various triggers such as chronic stress.

Pomalidomide
Pomalidomide is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013, by the US Food and Drug Administration as a treatment for relapsed and refractory multiple myeloma.

Pravastatin
Pravastatin, sold under the brand name Pravachol among others, is a statin medication, used for preventing cardiovascular disease in those at high risk and treating abnormal lipids. It should be used together with diet changes, exercise, and weight loss. It is taken by mouth.

Protein-bound paclitaxel
Protein-bound paclitaxel, also known as nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and pancreatic cancer, among others.

Relatlimab
Relatlimab is a monoclonal antibody designed for the treatment of melanoma. It was developed by Bristol-Myers Squibb. It is a lymphocyte-activation gene 3 inhibitor.

Richard L. Gelb
Richard Lee Gelb was an American businessman from New York City. He was a consultant and director of various corporations and not-for-profit entities, and from 1960 to his retirement in 1995 was a senior executive at Bristol-Myers Squibb Company.

Romidepsin
Romidepsin, also known as Istodax, is an anticancer agent used in cutaneous T-cell lymphoma and other peripheral T-cell lymphomas.

Saxagliptin
Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic of the dipeptidyl peptidase-4 inhibitor class.

Stavudine
Stavudine, sold under the brand name Zerit among others, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure.

Stephen Sadove
Stephen Sadove is an American businessman. He is the former chairman and chief executive officer of Saks Incorporated.

Technetium (99mTc) sestamibi
Technetium sestamibi is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six methoxyisobutylisonitrile ligands. The anion is not defined. The generic drug became available late September 2008.

Thalidomide
Thalidomide, sold under the brand names Contergan, Thalomid among others, is a medication used to treat a number of cancers, graft-versus-host disease, and a number of skin conditions including complications of leprosy.

Triamcinolone acetonide
Triamcinolone acetonide is a synthetic corticosteroid medication used topically to treat various skin conditions, to relieve the discomfort of mouth sores, and intra-articularly by proceduralists to treat various joint conditions.

Union de Pharmacologie Scientifique Appliquée
The Union de pharmacologie scientifique appliquée is a French pharmaceutical group, independent from 1935 until acquisition by Bristol Myers Squibb in 1994. The company is now owned by Taisho Pharmaceutical. It was founded in Agen in 1935 by Dr Camille Bru.

Urelumab
Urelumab is a fully human IgG4 monoclonal antibody developed by Bristol-Myers Squibb for the treatment of cancer and solid tumors. Urelumab targets the extracellular domain of CD137.

Vinflunine
Vinflunine is a novel fluorinated vinca alkaloid derivative undergoing research for the treatment of bladder cancer.

ZymoGenetics
ZymoGenetics, Inc was one of the oldest biotechnology/pharmaceutical companies in the USA, based in Seattle, Washington. The company was involved in the development of therapeutic proteins. Located on Lake Union, the address of the ZymoGenetics headquarters was 1201 Eastlake Avenue East.